928789-29-1

Basic information

• Product Name: (4-{1-[2-(4-methyl-piperazin-1-yl)-acetyl]-piperidin-4-yl}-phenyl)-carbamic acid tert-butyl ester
• Synonyms: (4-{1-[2-(4-methyl-piperazin-1-yl)-acetyl]-piperidin-4-yl}-phenyl)-carbamic acid tert-butyl ester
• CAS NO: 928789-29-1
• Molecular Weight: 416.564
• Mol File: 928789-29-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4-{1-[2-(4-methyl-piperazin-1-yl)-acetyl]-piperidin-4-yl}-phenyl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-{1-[2-(4-methyl-piperazin-1-yl)-acetyl]-piperidin-4-yl}-phenyl)-carbamic acid tert-butyl ester(928789-29-1)
• EPA Substance Registry System: (4-{1-[2-(4-methyl-piperazin-1-yl)-acetyl]-piperidin-4-yl}-phenyl)-carbamic acid tert-butyl ester(928789-29-1)

Safety Data

• Hazardous Substances Data: 928789-29-1(Hazardous Substances Data)

Upstream product

• 887589-58-4 [4-(4-piperidinyl)phenyl]carbamic acid 1,1-dimethylethylester 
• 54699-92-2 (4-Methyl-piperazin-1-yl)-acetic acid 

Downstream Products

• 928789-30-4 1-[4-(4-Amino-phenyl)-piperidin-1-yl]-2-(4-methyl-piperazin-1-yl)-ethanone 

Relevant articles and documents

5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase

The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein: W, A, Y, Z, R101 and R200 are described in the specification.